Tumor budding as a standardized parameter in gastrointestinal carcinomas: more than just the colon.
Berg KB, Schaeffer DF.
Mod Pathol. 2018 Jun;31(6):862-872. doi: 10.1038/s41379-018-0028-4. Epub 2018 Feb 6.
Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update.
Salehi F, Kovacs K, Scheithauer BW, Lloyd RV, Cusimano M.
Endocr Relat Cancer. 2008 Sep;15(3):721-43. doi: 10.1677/ERC-08-0012.
Complications of acromegaly: thyroid and colon.
Tirosh A, Shimon I.
Pituitary. 2017 Feb;20(1):70-75. doi: 10.1007/s11102-016-0744-z.
Mixed epithelial endocrine neoplasms of the colon and rectum - An evolution over time: A systematic review.
Kanthan R, Tharmaradinam S, Asif T, Ahmed S, Kanthan SC.
World J Gastroenterol. 2020 Sep 14;26(34):5181-5206. doi: 10.3748/wjg.v26.i34.5181.
[Mixed endocrine tumors].
Hervieu V, Scoazec JY.
Ann Pathol. 2005 Dec;25(6):511-28. doi: 10.1016/s0242-6498(05)86164-4.
Abdominal surgery. 2.
Welch CE.
N Engl J Med. 1973 Mar 29;288(13):661-72. doi: 10.1056/NEJM197303292881306.
Targeting estrogen receptors in colorectal cancer.
Maingi JW, Tang S, Liu S, Ngenya W, Bao E.
Mol Biol Rep. 2020 May;47(5):4087-4091. doi: 10.1007/s11033-020-05414-6. Epub 2020 Apr 3.
Medullary carcinoma in the colon.
Kelly ML.
ANZ J Surg. 2023 Mar;93(3):710-711. doi: 10.1111/ans.17901. Epub 2022 Jul 4.
The Neurotensinergic System: A Target for Cancer Treatment.
Sánchez ML, Coveñas R.
Curr Med Chem. 2022;29(18):3231-3260. doi: 10.2174/0929867328666211027124328.
Highly penetrant hereditary cancer syndromes.
Nagy R, Sweet K, Eng C.
Oncogene. 2004 Aug 23;23(38):6445-70. doi: 10.1038/sj.onc.1207714.
